Document Detail

Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance.
MedLine Citation:
PMID:  12744714     Owner:  NLM     Status:  MEDLINE    
Allergic rhinoconjunctivitis is a common condition with a peak incidence in the age range of the majority of elite athletes. The condition has been shown to have a significant impact on the quality of life of those affected and poses particular challenges when present in the elite athlete. When an athlete is looking for exceptional performance at events such as the Olympic Games, any factor which affects quality of life by interfering with sleep, decreasing the ability to concentrate, or reducing peak physical fitness, may have a significant impact on the ability to perform at one's best. Optimal management begins with correct diagnosis and identification of triggering factors. There are a number of therapeutic options available to the treating physician. When formulating a management plan for the elite athlete, the physician must consider "doping" rules and the possible effect of medication on athletic performance. Medication choices include the newer, non-sedating antihistamines, used either orally or topically, and the prophylactic use of intranasal corticosteroids. When allergic conjunctivitis is the principal problem, the newer, topical antihistamines are highly effective and have a rapid onset of action. Since avoidance strategies are rarely practical for the athlete, consideration should be given to strategies such as immunotherapy, where long-term benefit is possible.
Constance H Katelaris; Fiona M Carrozzi; Therese V Burke
Related Documents :
15754814 - Quality quagmire. why systems and processes are important to your practice but often ig...
1485154 - War-wounded refugees. quality of life after 2-3 years in sweden.
24988094 - Medical evacuations from oil rigs off the gulf coast of the united states from 2008 to ...
8006924 - Quality assurance of medical software.
12521454 - Who is responsible for the rising caesarean section rate?
3041834 - Antley-bixler syndrome from a prognostic perspective: report of a case and review of th...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Sports medicine (Auckland, N.Z.)     Volume:  33     ISSN:  0112-1642     ISO Abbreviation:  Sports Med     Publication Date:  2003  
Date Detail:
Created Date:  2003-05-14     Completed Date:  2003-09-26     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  8412297     Medline TA:  Sports Med     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  401-6     Citation Subset:  IM    
Institute of Immunology and Allergy Research, Westmead Hospital, Westmead 2145, Sydney, New South Wales, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Administration, Intranasal
Adrenal Cortex Hormones / administration & dosage
Anti-Asthmatic Agents / therapeutic use
Chronic Disease
Conjunctivitis, Allergic / complications,  drug therapy*
Histamine H1 Antagonists / therapeutic use
Immunotherapy / methods
Ipratropium / therapeutic use
Nasal Decongestants / therapeutic use
Quality of Life*
Rhinitis, Allergic, Perennial / complications,  drug therapy*
Sports Medicine / methods*
Task Performance and Analysis*
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Anti-Asthmatic Agents; 0/Histamine H1 Antagonists; 0/Nasal Decongestants; 60205-81-4/Ipratropium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Marijuana as doping in sports.
Next Document:  The concept of maximal lactate steady state: a bridge between biochemistry, physiology and sport sci...